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Abstract
Background: Apolipoprotein E (APOE) and elastin (ELN) are plausible candidate genes involved in
the pathogenesis of stroke. We tested for association of variants in APOE  and  ELN  with
subarachnoid hemorrhage (SAH) in a population-based study. We genotyped 12 single nucleotide
polymorphisms (SNPs) on APOE and 10 SNPs on ELN in a sample of 309 Caucasian individuals, of
whom 107 are SAH cases and 202 are age-, race-, and gender-matched controls from the Greater
Cincinnati/Northern Kentucky region. Associations were tested at genotype, allele, and haplotype
levels. A genomic control analysis was performed to check for spurious associations resulting from
population substructure.
Results: At the APOE locus, no individual SNP was associated with SAH after correction for
multiple comparisons. Haplotype analysis revealed significant association of the major haplotype
(Hap1) in APOE with SAH (p = 0.001). The association stemmed from both the 5' promoter and
the 3' region of the APOE gene. APOE ε2 and ε 4 were not significantly associated with SAH. No
association was observed for ELN at genotype, allele, or haplotype level and our study failed to
confirm previous reports of ELN association with aneurysmal SAH.
Conclusion: This study suggests a role of the APOE gene in the etiology of aneurysmal SAH.
Background
Non-traumatic, spontaneous subarachnoid hemorrhage
(SAH) affects 16,000 to 17,000 individuals each year in
the United States [1-3]. SAH has a 30-day mortality rate
exceeding 40%, and surviving patients often demonstrate
significant morbidity [2,4]. Over 80% of SAH can be
attributed to intracranial aneurysm (IA) rupture. Familial
aggregation studies of SAH have consistently identified an
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increased risk of a first-degree relative with SAH or family
history of SAH independent of smoking and hypertension
[5].
Variants of the apolipoprotein E (APOE) gene have been
associated with Alzheimer's disease, lipid disorders and
cardiovascular disease [6-8]. Previous studies have dem-
onstrated that APOE ε4 and/or APOE ε2 are associated
with lobar intracerebral hemorrhage (ICH) [9,10]. We
recently reported that haplotypes which include polymor-
phisms in the 5' untranslated region of the APOE gene are
risk factors for lobar ICH [11]. Specific to SAH, Kokubo et
al. [12] found significant association of APOE  ε4 with
SAH in a Japanese population. Niskakangas et al. [13]
reported association of APOE ε4 with adverse outcome
after aneurysmal SAH. No study on other polymorphisms
of APOE with regard to risk of SAH has yet been reported.
In addition to APOE, the elastin (ELN) gene emerged as a
putative gene for IA after linkage was found on 7q11,
where  ELN  is located [14]. However, prior association
studies of SNPs in ELN  have been contradictory and
remain inconclusive [15,16]. Further, few studies have
been performed in US populations.
We performed a case-control study examining the associ-




The methodology of the Genetic and Environmental Risk
Factors of Hemorrhagic Stroke study have been previously
reported [5,11]. Cases of potential ICH or SAH in the
Greater Cincinnati and Northern Kentucky are identified
by surveillance of 16 hospital emergency and radiology
departments and through monitoring of hospital dis-
charge diagnoses. Eligible cases are ≥ 18 years, are without
trauma or brain tumor as the cause of hemorrhage, and
reside within a 50-mile radius of the University of Cincin-
nati. A subset of cases was invited to enroll in a direct
interview and genetic sampling arm of the study. The
response rate was reasonable with over 60% of the cases
agreeing to participate. Two controls for each interviewed
case, matched by age (± 5 years), race, and gender were
recruited from the general population through random
digit dialing. Controls were informed of their participa-
tion in a risk factor study. Institutional Review Boards at
each hospital approved the study, and informed consents
were obtained from the participants.
SAH was defined as non-traumatic abrupt onset of severe
headache or altered level of consciousness associated with
blood in the subarachnoid space on CT or at autopsy, or
with a clinical history and examination consistent with
SAH where xanthochromia and increased red blood cells
are found in the cerebrospinal fluid.
A total of 309 Caucasians were included for analysis, of
which 107 were SAH cases matched to 202 controls. There
was no significant difference in the average age of cases
and controls (51.48 ± 12.93 yrs vs. 50.68 ± 12.23 yrs; p =
0.521) or gender distribution (64.4% vs. 64.8% female; p
= 0.992) between the cases and the controls. We also gen-
otyped samples from a small group of African American
subjects. However, the limited sample size (24 cases and
43 matched controls) lacked sufficient power to identify
associations. Thus, our results refer only to Caucasian
cases and controls.
DNA analysis
Buccal swabs were collected from each participant at the
time of interview, and DNA was extracted by standard
methods. Genotyping for APOE ε2/ε3/ε4 alleles was per-
formed by RFLP [17]. For analysis of the SNP markers,
genomic DNA was preamplified by whole genome ampli-
fication (WGA) using improved-primer extension pream-
plification. The WGA kit (High-Fidelity Expand Template
System) was obtained from Roche Pharmaceuticals. Five
nanograms of DNA was subjected to WGA and then
diluted 50-fold, of which 2 µl was used for SNP genotyp-
ing. The WGA protocols are validated for analysis of
genetic markers in our laboratory [18].
The TaqMan™ (fluorogenic 5' nuclease) assay was used for
SNP genotyping. The primers and probes were obtained
from Applied Biosystems. PCR was conducted in ABI
9700 thermocyclers, and the end-point results scored
using the ABI 7900HT Sequence Detection System. In
each 384-well plate, two reference samples and two nega-
tive controls were included for quality control.
We analyzed 12 SNPs spanning a 16 kb fragment on the
APOE gene (Table 1) of which five upstream markers are
now assigned locations on the TOMM40 gene [19]. Phys-
ical distance between the most distal 3'SNP (rs10119) on
TOMM40 and the most proximal 5'SNP (rs769446) on
APOE is approximately 2 kb. These 12 SNPs were ana-
lyzed in our previous study on ICH, which showed haplo-
typic association with lobar ICH [11]. We selected 10
SNPs on the ELN gene (Table 2), which were reported in
previous association studies involving aneurysmal SAH
[14-16].
Statistical methods
Allele frequencies were estimated by gene counting. Con-
formity of genotype proportions to Hardy-Weinberg equi-
librium (HWE) was tested by a goodness-of-fit χ2 test.
Haplotype frequencies and probabilities of haplotype
pairs for each individual were estimated by PHASE ver-BMC Medical Genetics 2007, 8:49 http://www.biomedcentral.com/1471-2350/8/49
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sion 2.1. PHASE implements Bayesian methods for esti-
mating haplotypes from population data [20]. Allele and
genotype frequency differences were tested using allelic
and genotypic χ2 tests, respectively. Haplotype associa-
tions were tested using χ2 and haplotype trend regression
(HTR) [21]. All p-values for allele, genotype and haplo-
type associations were empirically determined by Monte
Carlo simulations as described by Becker and colleagues
[22,23]. Multiple testing was accounted for by testing a
global hypothesis of no association for each of the single
locus and haplotype test [22,23].
Genomic control
We performed a genomic control analysis to adjust for
population substructure [24]. This was done by typing 30
unlinked SNPs distributed throughout the genome as null
markers in all samples (cases and controls) and conduct-
ing test statistics to estimate λ following the methods as
described [25].
Results
Genetic variation at the APOE locus
Genotype and allele frequencies among the cases and the
controls are presented in Table 3. Genotypes at all 12
markers were in HWE. We did not observe significant
association either at allelic or genotypic level (global p =
0.452 and 0.807, respectively). Marginal frequency differ-
ences between cases and controls at allelic and genotype
levels were observed in SNP 1 and 4 (Table 3). We per-
formed a separate analysis for the isoformic ε2/ε3/ε4 alle-
les, which also revealed no significant association (Table
4).
We conducted an analysis to test for association at the
haplotype level based on data from all 12 SNPs (Table 5).
Using PHASE, we observed a total of 66 haplotypes. In
Table 5, we present data on 9 common haplotypes (fre-
quency >0.02 in either cases or controls as inferred by
PHASE. TGTCGATCCTTC (Hap1) was inferred as the
most common haplotype, which accounted for 30% and
19% of all haplotypes in cases and controls, respectively.
Global tests of association were significant for both χ2 test
and HTR (p = 0.019 and 0.036, respectively). Among all
haplotypes, Hap1 showed significant difference between
cases and controls by both methods (Table 5).
To explore the haplotype association at a finer level, we
conducted a 'sliding haplotype' analysis to decompose
Table 1: Distribution of the studied SNPs in the APOE gene region
SNP No. dbSNP ID (*) NCBI Location Genomic Location
SNP1 rs157581 (TC) 17663932 TOMM40 EX2
SNP2 rs1160983 (GA) 17665447 TOMM40 EX5
SNP3 rs1160985 (TC) 17671630 TOMM40 IN5
SNP4 rs1160984 (CT) 17672142 TOMM40 IN5
SNP5 rs10119 (GA) 17674891 TOMM40 3'UTR
SNP6 rs769446 (AT) 17676846 APOE Promoter
SNP7 rs405509 (TC) 17677054 APOE Promoter
SNP8 rs440446 (CG) 17677385 APOE 5'UTR
SNP9 rs769452 (CT) 17679328 APOE EX2
SNP10 rs429358(TC) 17680159 APOE EX4
SNP11 rs769455 (TC) 17680258 APOE EX4
SNP12 rs7412 (CT) 17680297 APOE EX4
Table 2: Distribution of the studied SNPs in the ELN gene
SNP No. dbSNP ID (*)  NCBI Location Genomic Location
SNP1 rs3757584 (GT) 11474039 5' UTR
SNP2 rs868005 (AG) 11478458 IN1
SNP3 rs2301995 (CT) 11485484 IN4
SNP4 rs2301994 (CT) 11485607 IN4
SNP5 rs3801459 (AC) 11487753 IN4
SNP6 rs13229379 (AC) 11489504 IN5
SNP7 rs2239691 (GA) 11502513 IN19
SNP8 rs2071307 (CT) 11504058 EX20
SNP9 rs104272300 (GA) 11507178 IN22
SNP10 rs3757587 (CT) 11514372 IN31
(*) In Tables 1 and 2, the second nucleotide position under dbSNP ID represents the minor allele.BMC Medical Genetics 2007, 8:49 http://www.biomedcentral.com/1471-2350/8/49
Page 4 of 7
(page number not for citation purposes)
Hap1, the most common and significantly associated
haplotype. None of the other haplotypes showed signifi-
cant association even with the sliding window analyses
(data not shown), and they were consequently dropped
from further analysis. A graphical representation of this
analysis is presented in Figure 1. The uppermost circle in
the figure, with the number '1–12', represents Hap1
inferred using all SNPs (SNPs 1 to12). Progressively
smaller windows of this haplotype were formed at each
level of the pyramid. These depict windows created with
combinations of SNPs used in haplotype construction for
that level (e.g., circle 1–11 represents the most common
haplotype formed by SNPs 1 to 11, circle 2–12 represents
the most common haplotype formed by SNPs 2 to 12, and
so on). Haplotypes with significant associations are
shown in yellow (p ~ 0.05–0.1), green (p ~ 0.01–0.05)
and red (p < 0.01). A trend of ascending significance is
observed at the 5' region. Marginal associations are also
observed at the 3' region, where SNPs encoding the isofor-
mic  ε2/ε3/ε4 variants are located (SNP10 and SNP12
together form the ε2/ε3/ε4 variants – cytosine at both sites
result in the ε4 isoform, thymine at the first site and cyto-
sine at the second site form ε3, and thymine at both sites
yield ε2).
Genetic variation at the ELN locus
Genotype and allele frequencies of ELN SNPs among the
cases with aneurysmal SAH and controls are presented in
Table 6. Genotypes were in HWE with the exception of
SNP2 and SNP7. One marker rs13229379  (SNP6) was
found to be monomorphic in our population and was
thus dropped from subsequent analysis. None of the SNPs
were associated with SAH.
Using PHASE, we inferred haplotypes based on all 9 SNPs
and did not observe significant associations (global p =
Table 5: APOE haplotype frequencies inferred by PHASE and 
HTR and the corresponding p-values showing the levels of 
difference between cases and controls.
Haplotype Frequency p-CS p-HTR
Cases Controls
TGTCGATCCTTC (Hap1) 0.296 0.194 0.001 0.001
TGCCGATGCTTC (Hap2) 0.148 0.140 0.689 0.123
CGCCAATCCTTC (Hap3) 0.074 0.068 0.704 0.216
TGCCATTGCTTC (Hap4) 0.047 0.053 0.821 0.793
TGTCGATCCCTC (Hap5) 0.050 0.040 0.438 0.203
TGCCGACGCTTC (Hap6) 0.029 0.024 0.958 0.168
TGCCATTCCTTC (Hap7) 0.035 0.025 0.521 0.086
TGTTGATCCTTC (Hap8) 0.030 0.048 0.264 0.813
TGCCGATGCCTC (Hap9) 0.021 0.034 0.309 0.647
Rare Haplotypes (<0.2) 0.271 0.374
Global Test 0.019 0.036
p-CS : empirical p-values based on chi square test statistics, p-HTR: 
empirical p-values based on haplotype trend regression test statistics.
Table 4: Distribution of APOE ε2/ε3/ε4 alleles and genotypes
Case (freq) Control (freq) P
Genotype
ε2/ε2 0 1 (0.005) 0.998
ε2/ε3 10 (0.106) 32 (0.174) 0.162
ε2/ε4 1 (0.011) 2 (0.011) 0.997
ε3/ε3 61 (0.649) 97 (0.527) 0.069
ε3/ε4 20 (0.213) 46 (0.250) 0.557
ε4/ε4 2 (0.021) 6 (0.033) 0.727
Allele
ε2 11 (0.058) 36 (0.098) 0.143
ε3 152 (0.808) 272 (0.740) 0.073
ε4 25 (0.132) 52 (0.163) 0.386
Table 3: Distribution of genotypes and allele frequencies at the 
APOE gene in the Caucasian cases and controls
Locus Genotype Freq(q) Cases vs. Controls 
(p-value)
AA Aa aa Allele Genotype
SNP1 70 32 1 0.165 0.056 0.142
107 71 7 0.230
SNP2 102 4 0 0.019 0.371 0.641
184 11 1 0.033
SNP3 23 53 25 0.490 0.518 0.738
41 93 55 0.463
SNP4 95 7 0 0.034 0.062 0.144
162 22 3 0.075
SNP5 55 41 5 0.252 0.570 0.589
91 66 14 0.275
SNP6 74 27 2 0.150 0.164 0.327
124 69 4 0.195
SNP7 81 19 0 0.095 0.536 0.503
145 35 3 0.112
SNP8 45 50 10 0.333 0.304 0.548
75 95 26 0.375
SNP9 104 1 0 0.005 0.289 0.760
185 3 1 0.013
SNP10 71 21 2 0.133 0.361 0.675
130 48 6 0.163
SNP11 105 0 0 - 0.145 0.145
194 5 0 0.013
SNP12 83 11 0 0.059 0.108 0.213
149 34 1 0.098
Global 0.452 0.807
Note: In Tables 3 and 6, Genotype 'aa' represents the minor 
homozygous genotype; the first row corresponding to each SNP 
marker presents the data on cases and the second row presents the 
data on controls.BMC Medical Genetics 2007, 8:49 http://www.biomedcentral.com/1471-2350/8/49
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0.229 and 0.198; Table 7). There was no association of
haplotypes even after excluding the two markers (SNP2
and SNP7) that were not in HWE (data not shown). Fur-
ther, the sliding window analysis showed no association
between ELN and SAH.
Discussion
Although we did not observe significant association of the
APOE variants and also could not confirm the association
of APOE ε4 with SAH, we did find an association between
SAH and the most common APOE  haplotype, which
occurred in nearly 1/3 of the SAH cases compared to 1/5
of controls. This haplotype included regulatory regions of
the gene in the 5' untranslated region. Since variations of
the 5' regulatory region are traditionally associated with
decreased or increased expression of the gene, we hypoth-
esize that regulation of APOE is the primary mechanism
of association of this gene with SAH. We have not exam-
ined the 3' untranslated region and our most distal 3' SNP
was within the last exon of the gene. Variations in the 3'
untranslated region are associated with post-transcrip-
tional processing and we are unable to comment upon
variations in these regions.
Our recent study in lobar ICH demonstrated that in addi-
tion to the association of APOE ε4 with lobar ICH, APOE
haplotypes, which include non-coding variants in regula-
tory regions, mediate the risk of lobar ICH [11]. These
findings underscore the importance of regulatory variants,
in addition to coding sequences, in understanding the
genetic basis of complex diseases.
Haplotypes have the advantage of providing information
not only on the relationship of disease to a single poly-
morphism, but also on variants that are in linkage dise-
quilibrium with the markers tested. The selection of large
haplotypes may lead to "over-partitioning" in which hap-
lotypes with very small frequencies may be spuriously
associated with the phenotype in question. In our study,
the most common haplotype was associated with the phe-
notype, making over-partitioning a less-likely con-
founder.
Table 6: Distribution of genotypes and allele frequencies at the ELN gene in the Caucasian cases and controls
Locus Genotype Freq(q) Cases vs. Controls (p-value)
AA Aa Aa Allele Genotype
SNP1 79 11 0 0.061 0.851 0.774
141 16 1 0.057
SNP2 33 42 14 0.393 0.863 0.968
56 71 26 0.402
SNP3 79 11 0 0.061 0.729 0.906
138 20 1 0.069
SNP4 81 9 2 0.070 0.544 0.851
144 22 4 0.088
SNP5 76 11 0 0.063 0.860 0.574
142 18 2 0.067
SNP7 34 42 15 0.395 0.948 0.998
63 76 27 0.391
SNP8 35 43 14 0.386 1 0.875
63 84 23 0.382
SNP9 47 12 5 0.172 0.399 0.697
83 24 14 0.215
SNP10 77 12 3 0.098 0.297 0.027
126 42 1 0.130
Global Test 0.847 0.153
Sliding Window Analysis of Hap1 (TGTCGATCCTTC) Figure 1
Sliding Window Analysis of Hap1 (TGTCGATC-
CTTC). Each circle depicts the most common haplotype 
created by the SNPs indicated (e.g., circle 1–12 represents 
the most common haplotype formed by SNPs 1 to 12). Signif-
icance level of the most common haplotype is indicated by 
color: yellow (p ~ 0.05–0.1), green (p ~ 0.01–0.05) and red (p 
< 0.01). Global significance for sliding window is 0.013.BMC Medical Genetics 2007, 8:49 http://www.biomedcentral.com/1471-2350/8/49
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The primary function of APOE in lipid metabolism is to
mediate the interaction of lipid particles with LDL and
APOE receptors. The involvement of APOE  polymor-
phisms in lipid metabolism, Alzheimer's disease, and a
host of cardiovascular and cerebrovascular diseases imply
pleiotropic effects of the gene [6-8]. Although outcome
studies have implicated APOE ε4 as a risk allele for cogni-
tive impairment following subacute phase of aneurysmal
SAH [26] and a recent meta-analysis showed marginal
association of ε4 carriers with SAH [27], the biological
role of APOE in the etiology of SAH remains unclear.
Based on epidemiologic studies showing association of
lower cholesterol levels to hemorrhagic stroke including
subarachnoid hemorrhage [28-30], it may be speculated
that lipid metabolism involving APOE contributes to risk
of SAH or its adverse outcomes.
A significant advantage of our study is the inclusion of
polymorphisms other than those that code for APOE ε2
and APOE ε4. The overall haplotype spans a large region
of the 5' untranslated region and the exons of the APOE
gene, which allows for an examination of the regulatory
regions. The sliding window analysis provides a compel-
ling indication of association, which emerges from the 5'
region of the gene. To our knowledge, no other study has
examined any other SNPs of the APOE gene and risk of
SAH.
The association of ELN with SAH has not been consistent.
Using an affected sib-pair design, Onda et al. [14] first
reported linkage of familial IA to chromosome 7q11 in
Japanese families. The putative locus was later confirmed
by linkage in a set of extended pedigrees from Utah [31].
However, two other linkage studies, from Japan and Fin-
land, did not replicate these findings [32,33]. A putative
candidate gene, ELN, which maps to 7q11, raised the
expectation of its association with IAs.
Although we did not find significant association either at
allelic or haplotype levels, we do not to rule out the pos-
sible association of ELN with SAH. Differences in allele
frequencies and haplotype structures among populations
could influence association results. The allele frequencies
for many SNPs in our population were different from
those reported in the Japanese population [14]. Further,
an associated polymorphism could be in LD with the
functional variant and not be the functional variant by
itself. Variation in LD pattern across populations, there-
fore, would be important in assessing association.
Case-control association designs should be viewed with
caution because spurious association could be introduced
by unrecognized population substructure. To guard
against such false associations, we used a genomic control
approach in which null markers distributed throughout
the genome are used to adjust the association test statistics
[24]. The adjustment is carried out by estimating a vari-
ance inflation factor, λ, from the distribution of the test
statistics at the null loci. In the absence of substructure, λ
is 1 and the genomic control approach is equivalent to a
standard case-control test. A major strength of our study
was that we used genomic control to evaluate and correct
for any population substructure in our samples. The λ
value obtained form the 30 null SNPs was 1.06. This
clearly illustrates absence of any major population strati-
fication in our samples, which suggests that our results of
association or lack thereof remain valid.
Conclusion
In conclusion, our study suggests a plausible role of the
upstream regulatory region of APOE in the etiology of
aneurysmal SAH. The complexity of the biological mech-
anisms underlying ELN in conjunction with genetic heter-
ogeneity among ethnically diverse populations could
influence our observed lack of association. Further studies
with larger sample sizes and in additional ethnic groups
are required to establish the likely involvement of ELN
variants in SAH.
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